Back
PAB
Patrys Limited
๐ฆ๐บ ASX
๐ HIGH PRICE GROWTH
๐งฌ BIOTECHNOLOGY
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 9.29%
Annual Growth
5 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
5
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2007-07-13. The Companyโs deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). The company has developed two humanized forms of deoxymab 3E10, both have improved activity over the original deoxymab 3E10 antibody. PAT-DX1 is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, while PAT-DX3 is a full-sized IgG antibody. In a range of pre-clinical studies, PAT-DX1 has shown an ability to kill cancer cells in cell models, human tumor explants, xenograft and orthotopic models. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. This allows specific delivery of cancer drugs to multiple types of cancer.
๐ Performance
Price History
+251.48%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.04
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in PAB
5
๐ Total Capital Earnings
$1K
๐ Average investment frequency
15 weeks
๐ต Average investment amount
$1,582
โฐ Last time a customer invested in PAB
2 days
PAB investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
14%
100k - 150k
50k - 100k
43%
Less than 50k
43%
๐ถ Age of investors
18 - 25
20%
26 - 34
40%
35 - 90
40%
๐ Legal gender of investors
Female
Male
100%
Pearlers who invest in PAB also invest in...
DHHF is an all-in-one investment solution, constructed using a passive blend of cost-effective ETFs traded on the ASX and other global exchanges. The ETF has a 100% allocation to shares, and is invested in a blend of large, mid and small cap equities from Australia, global developed and emerging markets, offering investors exposure to an โall-cap, all-worldโ share portfolio with the potential for high growth over the long term. The ETF provides exposure to approximately 8,000 equity securities listed on over 60 global exchanges, in one ASX trade.
๐ Performance (5Yr p.a)
13.42%
๐ Share price
$40.60 AUD
๐ HIGH PRICE GROWTH
๐ GLOBAL
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
22.88%
๐ Share price
$69.16 AUD
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
17.88%
๐ Share price
$154.45 AUD
๐ค TECHNOLOGY
๐ GLOBAL
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
Want more shares? Try these...